BlueCrest Capital Management’s Seagen Inc. Common Stock SGEN Stock Holding History

BlueCrest Capital Management’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,789	Closed	-$324K	–	633
2019 Q3	$324K	Buy	+3,789	New	+$278K	0.02%	348
2018 Q3	–	Sell	-11,008	Closed	-$731K	–	1870
2018 Q2	$731K	Sell	11,008 -2,076	-16%	-$119K	0.02%	648
2018 Q1	$685K	Buy	13,084 +6,804	+108%	+$371K	0.02%	611
2017 Q4	$336K	Buy	+6,280	New	+$367K	0.01%	602
2016 Q4	–	Sell	-12,701	Closed	-$686K	–	924
2016 Q3	$686K	Buy	12,701 +5,022	+65%	+$238K	0.02%	446
2016 Q2	$310K	Buy	+7,679	New	+$292K	0.01%	680
2016 Q1	–	Sell	-12,777	Closed	-$573K	–	1179
2015 Q4	$573K	Buy	+12,777	New	+$532K	0.02%	539
2015 Q3	–	Sell	-35,216	Closed	-$1.7M	–	1084
2015 Q2	$1.7M	Buy	+35,216	New	+$1.45M	0.05%	390

Other funds holding SGEN

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

BlueCrest Capital Management's SGEN Position: Q4 2019 in Review

BlueCrest Capital Management sold out of Seagen Inc. Common Stock (SGEN) in Q4 2019, closing a stake of 3,789 shares — an estimated $324K sold.

BlueCrest Capital Management first reported a position in SGEN in Q2 2015 and held it in 8 quarters. The position peaked at $1.7M in Q2 2015. 396 funds tracked by Wall St. Rank hold SGEN as of Q4 2019.

BlueCrest Capital Management reported no remaining Seagen Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
BlueCrest Capital Management sold 3,789 Seagen Inc. Common Stock shares in Q4 2019, an estimated $324K.
BlueCrest Capital Management first reported a position in Seagen Inc. Common Stock in Q2 2015 and held it in 8 quarters.
BlueCrest Capital Management's Seagen Inc. Common Stock position peaked at $1.7M in Q2 2015.
396 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2019.

Based on BlueCrest Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.